Evaluation of the API-VIGIE Monitoring System: Program to Reduce Emergency Visits for Severe Paroxysmal Alcoholism (EVAL-APIVIGIE)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT05173116|
Recruitment Status : Withdrawn (protocol not implemented for logistical reasons in the recruiting center, possible rescheduling.)
First Posted : December 29, 2021
Last Update Posted : January 11, 2023
|Condition or disease||Intervention/treatment|
|Intoxication;Alcohol;Acute Emergencies||Other: Medical Outcomes Study Short Form 36 (SF 36) Other: observationnal study|
In France, between 10% and 30% of emergency room admissions are linked to problematic alcohol consumption. This considerable weight of alcohol-related problems in the current problematic of emergencies is largely unknown and can lead to blockages in emergencies.
For acute intoxication requiring emergency care, 80% of admissions concern people dependent on alcohol. Here again, this crucial clinical notion is largely ignored: when a patient in a state of intoxication arrives in the emergency room, this should not be considered as a banal and one-off event, it is necessary to put in place a care, if necessary, of addiction.
Supported by a call for projects from the Hauts-de-France Regional Health Agency, the Addictions Service of the Arras Hospital is setting up a monitoring system called APIVIGIE.
APIVIGIE program is offered to patients who present to the emergency room for a diagnosis of API after an evaluation by the liaison team of the addiction service. If the patient agrees to be part of the program, he will receive a resource card with the APIVIGIE phone number to contact if necessary.
The link will be maintained with the Addictology Care, Support and Prevention Center (CSAPA) for a period of 6 months, by telephone consultations, or by video-consultations or face-to-face consultations.
|Study Type :||Observational|
|Actual Enrollment :||0 participants|
|Official Title:||Evaluation of API-VIGIE Monitoring System: Program to Reduce Emergency Visits for Severe Paroxysmal Alcoholism|
|Estimated Study Start Date :||February 2022|
|Estimated Primary Completion Date :||February 2023|
|Estimated Study Completion Date :||August 2023|
API-VIGIE program adult participant who agreed to participate in the study
Other: Medical Outcomes Study Short Form 36 (SF 36)
completion of questionnaire quality of life SF 36 (inclusion, Month 3, Month 6).
Any stay for adults patients in the emergency room of the ARRAS hospital for API during the period covered (from 1 year before to 1 year after the installation of the APIVIGIE program) (main diagnosis or associated with an API (F10.0 according to the ICD-10 classification used by Department of Medical Information)
Other: observationnal study
- Number of visits to the Emergency Reception Service for Significant Paroxysmal Alcoholics [ Time Frame: during 2 years ]1 year before implementation of the program and up to 1 year after implementation of the program
- weekly consumption of alcoholic beverages [ Time Frame: Inclusion , Visit 2 (Month 3) and visit 3 (Month 6) ]
- weekly consumption of other substances (cannabis, other substances) [ Time Frame: Inclusion , Visit 2 (Month 3) and visit 3 (Month 6) ]
- Quality of life score, measured by the Medical Outcomes Study Short Form 36 (SF-36) health scale score. [ Time Frame: Inclusion , Visit 2 (Month 3) and visit 3 (Month 6) ]SF 36 giving a score from 0 to 100. More higher score, more better quality of life.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05173116
|Principal Investigator:||Dominique LEJEUNE, M.D||Centre Hospitalier Arras|